av/structure_therapeutics--big.svg

NASDAQ:GPCR

Structure Therapeutics

  • Stock

USD

Last Close

33.47

06/11 21:01

Market Cap

2.25B

Beta: -

Volume Today

656.36K

Avg: 1.02M

PE Ratio

−22.22

PFCF: −22.62

OverviewFinancialsAPI

    Description

    Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 ...Show More

    Earnings

    Earnings per Share (Estimate*)

    -1.2-1-0.8-0.6-0.4-0.22021-12-302023-02-032023-03-312024-03-082024-11-132025-05-07

    Revenue (Estimate*)

    0.000.000.010.010.012021-12-302023-02-032023-03-312024-03-082024-11-132025-05-07

    *Estimate based on analyst consensus